2015
DOI: 10.1016/j.toxlet.2014.09.027
|View full text |Cite
|
Sign up to set email alerts
|

Protection against phalloidin-induced liver injury by oleanolic acid involves Nrf2 activation and suppression of Oatp1b2

Abstract: This study utilized pharmacological activation of Nrf2 with oleanolic acid (OA, 22.5 mg/kg, sc for 4d) and the genetic Nrf2 activation (Nrf2-null, wild-type, and Keap1-HKO mice) to examine the role of Nrf2 in protection against phalloidin hepatotoxicity. Mice were given phalloidin (1.5 mg/kg, ip for 8 h) to examine liver injury and the expression of toxicity-related genes. Phalloidin increased serum enzyme activities and caused extensive hepatic hemorrhage and necrosis in Nrf2-null and wild-type mice, but less… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 30 publications
(54 reference statements)
1
22
0
Order By: Relevance
“…Phalloidin is taken up by hepatocytes through the Oatp1b2 transporter, which was also suppressed by OA. Thus, protection against phalloidin hepatotoxicity by OA involves activation of Nrf2 and suppression of Oatp1b2, with Oatp1b2 mediating the uptake of phalloidin into the liver to produce toxicity …”
Section: Low Doses Of Oa Protect Against Hepatotoxicity Induced By Amentioning
confidence: 99%
See 2 more Smart Citations
“…Phalloidin is taken up by hepatocytes through the Oatp1b2 transporter, which was also suppressed by OA. Thus, protection against phalloidin hepatotoxicity by OA involves activation of Nrf2 and suppression of Oatp1b2, with Oatp1b2 mediating the uptake of phalloidin into the liver to produce toxicity …”
Section: Low Doses Of Oa Protect Against Hepatotoxicity Induced By Amentioning
confidence: 99%
“…Induction of Nrf2 (1) promotes GSH biosynthesis and GSH conjugation; (2) increases in Nqo1 and HO ‐1 detoxify electrophiles; (3) increases in Phase‐2 detoxification conjugation; and (4) increases in the Mrp efflux pumps to eliminate toxic bile acids out of hepatocytes . In addition, OA decreases CYP 2E1 to reduce bioactivation of CC l 4 and acetaminophen and decreases Oatp1b2 to reduce hepatic uptake of phalloidin . OA is a TGR 5 activator to produce proinflammatory cytokines in the biliary tree implicating in cholestasis…”
Section: Mechanisms For Paradoxical Hepatoprotective and Hepatotoxicmentioning
confidence: 99%
See 1 more Smart Citation
“…Many effects have recently been made to develop the complementary and alternative medicines for reducing oxidative stress and improving liver functions. Therapeutically effective agents from natural sources, exemplified by quercetin (Mariee et al 2012), silymarin (Ahmad et al 2013) and oleanolic acid (Lu et al 2014), are particularly attractive for treatments as they have the potential to reduce the risk of drug toxicity (Shivananjappa et al 2013). Ganoderma, a traditional Chinese medicinal mushroom, has been widely used for treating and preventing chronic hepatopathy of various etiologies (Peng et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…1 Recently, more and more attentions are paid to OA, due to its pharmacological activities, such as anti-inflammation, [2][3][4] antivirus, 5 antitumor, [6][7][8][9] hepatoprotective, [9][10][11] hypolipidemic and hypoglycemic effects. 1 Recently, more and more attentions are paid to OA, due to its pharmacological activities, such as anti-inflammation, [2][3][4] antivirus, 5 antitumor, [6][7][8][9] hepatoprotective, [9][10][11] hypolipidemic and hypoglycemic effects.…”
Section: Introductionmentioning
confidence: 99%